Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
BMC Immunology|March 23, 2018
Low HLA binding of diabetes-associated CD8+ T-cell epitopes is increased by post translational modificationsJohn Sidney, Jose Luis Vela, Dave Friedrich, et al.
The Keio Journal of Medicine|October 13, 2004
Peripheral B lymphocyte toleranceAmanda Gavin, Djemel Aït-Azzouzene, Annica Mårtensson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 2, 2011
Negative selection by IgM superantigen defines a B cell central tolerance compartment and reveals mutations allowing escapeBao Hoa Duong, Takayuki Ota, Miyo Aoki-Ota, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 24, 2013
Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activationNorihito Kawasaki, Jose Luis Vela, Corwin M Nycholat, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 17, 2010
Peripheral B cell tolerance and function in transgenic mice expressing an IgD superantigenBao Hoa Duong, Takayuki Ota, Djemel Aït-Azzouzene, et al.
Diabetologia|April 30, 2017
Metabolically inactive insulin analogue does not prevent autoimmune diabetes in NOD miceJuha Grönholm, Philippe P Pagni, Minh N Pham, et al.
The Journal of Experimental Medicine|December 30, 2009
Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivoBao Hoa Duong, Hua Tian, Takayuki Ota, et al.
Clinical Immunology (Orlando, Fla.)|January 29, 2016
Oral insulin (human, murine, or porcine) does not prevent diabetes in the non-obese diabetic mouseMinh N Pham, Claire Gibson, Anna K E Rydén, et al.
Nature Immunology|September 6, 2011
Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteriaYuki Kinjo, Petr Illarionov, José Luis Vela, et al.
Pageof 3